Norfenazin (Nortriptyline Hydrochloride)

Nortriptyline hydrochloride works by blocking the reuptake of the neurotransmitters norepinephrine and serotonin at presynaptic nerve terminals. This inhibition raises the levels of these monoamines in the synaptic cleft, enhancing neurotransmission in brain pathways that regulate mood, pain perception, and headache mechanisms. The drug also antagonises histamine, muscarinic and α1‑adrenergic receptors, contributing to its overall pharmacological profile.

The appropriate dose of Norfenazin is individualized and determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage titration typically starts at a low dose and is adjusted gradually to achieve therapeutic effect while minimizing adverse reactions. Patients should follow the exact regimen provided in their prescription label.

Safety data for nortriptyline during pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers usually advise discontinuation or substitution with a safer alternative during pregnancy and advise against breastfeeding while taking Norfenazin unless a risk‑benefit assessment justifies its use.

To place an order, submit an enquiry on the Norfenazin product page at gnhindia.com, specifying the required quantity and providing your institutional or trade credentials. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will respond with pricing, availability, shipping details—including any temperature‑controlled requirements—and the necessary import documentation to complete the transaction.

Compared with selective serotonin reuptake inhibitors (SSRIs), nortriptyline has a broader mechanism affecting both norepinephrine and serotonin, which can be advantageous for patients with mixed depressive symptoms or neuropathic pain. However, tricyclic antidepressants generally have a higher incidence of anticholinergic and cardiovascular side effects than newer agents. Choice of therapy depends on individual patient factors, comorbidities, and tolerability considerations evaluated by the prescriber.

Norfenazin should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original container, protect it from moisture, direct sunlight, and excessive heat. Do not store in bathrooms or near kitchen appliances. Ensure the packaging remains sealed until use to maintain product stability and potency.

Norfenazin is taken orally, usually as a tablet, with or without food as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed. Dosing time (morning or evening) may be adjusted to minimize drowsiness, and patients should follow the exact schedule indicated on their prescription label.

The most serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease or when combined with other QT‑prolonging drugs; seizures, which may occur at high doses or in susceptible individuals; severe hypotension; and serotonin syndrome when used with other serotonergic agents. Prompt medical attention is required if symptoms such as irregular heartbeat, convulsions, profound dizziness, or signs of serotonin excess appear.

Norfenazin is contraindicated in patients with known hypersensitivity to nortriptyline or other tricyclic antidepressants, those who have recently taken monoamine oxidase inhibitors (within 14 days), and individuals with recent myocardial infarction or uncontrolled narrow‑angle glaucoma. Caution is also advised for patients with severe hepatic or renal impairment, as dose adjustments may be necessary. The medication should not be used in children or adolescents unless specifically prescribed by a specialist.